Results 61 to 70 of about 21,488 (194)

Drug eluting stents a nightmare? [PDF]

Interactive CardioVascular and Thoracic Surgery, 2007
As a contribution to the controversial discussion for the use of drug-eluting stents, the European Heart Institute of the European Academy of Sciences and Arts is emphasizing important factors: a) drug eluting stents (DES) should be used only in accordance with their on-label indications for use; b) to avoid off-label use of DES and to assure that ...
openaire   +2 more sources

Vat Polymerization 3D Printing for Controlled Drug Release Applications

Advanced Materials Technologies, Volume 11, Issue 11, 5 June 2026.
ABSTRACT Vat polymerization (VP) 3D printing, a light‐based additive manufacturing technique, has emerged as a promising technique for fabricating complex drug delivery systems with high precision and spatial resolution. This layer‐by‐layer manufacturing process enables the creation of intricate geometries and customizable architectures, which are ...
Hafiz Busari, O. Thompson Mefford, M. Aaron Vaughn   +2 more
wiley   +1 more source

Mechanically Robust Biodegradable Stents With Theragenerative Vascular Responses via Combined 3D Printing and Janus Nanoengineering

Advanced Science, Volume 13, Issue 34, 19 June 2026.
This work introduces a theragenerative 3D‐printed biodegradable stent with Janus nanoarchitecture for spatially controlled vascular healing. A luminal tantalum ion–implanted surface accelerates endothelialization and hemocompatibility, while an abluminal sirolimus/poly‐L‐lactic acid–tantalum layer provides sustained drug release and suppresses smooth ...
Jong Hwa Seo, Dong‐Sung Won, Hyun Lee, Seojoon Bang, Hyeong Seok Kang, Ju Yeong Gwon, Chan Ho Moon, Ji Won Kim, Yubeen Park, Minho Kang, Dong Yun Lee, Donghyun Lim, Kisuk Yang, Gi Doo Cha, Soo‐Hong Lee, Tae‐Sik Jang, Seokbeom Kim, Jun‐Kyu Park, Jung‐Hoon Park, Hyun‐Do Jung   +19 more
wiley   +1 more source

Efficacy of Sirolimus-Eluting Stents Compared With Paclitaxel-Eluting Stents in an Unselected Population With Coronary Artery Disease: 24-Month Outcomes of Patients in a Prospective Non-randomized Registry in Southern Turkey

International Journal of Medical Sciences, 2010
Background: The efficacy of drug-eluting stents has been shown in randomized trials, but some controversy exists regarding which stent sirolimus-eluting or paclitaxel-eluting is more effective in unselected Turkish patients.
Davran Çiçek, Hasan Pekdemir, Nihat Kalay, Süleyman Binici, Hakan Altay, Haldun Müderrisoğlu
doaj  

Variability in ACT Response to Standard UFH Bolus During PCI: A Prospective Study on Determinants of Subtherapeutic Anticoagulation

Catheterization and Cardiovascular Interventions, Volume 107, Issue 7, Page 2293-2303, June 1, 2026.
ABSTRACT Background Unfractionated heparin (UFH) remains the standard anticoagulant during percutaneous coronary intervention (PCI), with guidelines recommending a target activated clotting time (ACT) of ≥250 s. However, despite receiving a standardized bolus dose, many patients fail to achieve this target.
Manh Cuong Vu, Antonin Trimaille, Amandine Granier, Adrien Carmona, Anis Elidrissi, Marion Kibler, Laurence Jesel, Patrick Ohlmann, Laurent Sattler, Olivier Morel   +9 more
wiley   +1 more source

A novel platinum chromium everolimus-eluting stent for the treatment of coronary artery disease

Biologics: Targets & Therapy, 2013
Johan Bennett, Christophe DuboisDepartment of Cardiovascular Diseases, University Hospitals Leuven, Leuven, BelgiumAbstract: The development of coronary stents represents a major step forward in the treatment of obstructive coronary artery disease since ...
Bennett J, Dubois C
doaj  

Recurrent and Multiple-site Stent Fractures in the Left Anterior Descending Artery: A Case Report and Literature Review

Journal of Medical Sciences, 2015
Coronary artery stent fracture (SF) occurs in drug-eluting stent (DES) era but recurrent and multiple DES fracture was rare. We report a case of recurrent and multiple-site SF and review the literature regarding the prevalence, possible mechanism, and ...
Shih-Jung Jang, Yu-Lin Ko
doaj   +1 more source

Two Case Reports of Percutaneous Intravascular Lithotripsy for the Treatment of Severe Coronary Artery Calcification

Clinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Severe coronary calcification is a common challenge in percutaneous coronary intervention, often resulting in suboptimal stent expansion. Intravascular lithotripsy (IVL) employs acoustic pressure waves to fracture calcified plaques and increase procedural success.
Liang‐cai Guo, Chi‐jun Hou, Yan‐jin Zeng, Wen Li   +3 more
wiley   +1 more source

Surface-Degradable Drug-Eluting Stent with Anticoagulation, Antiproliferation, and Endothelialization Functions

Biomolecules, 2019
Drug-eluting stents (DES) have been widely applied for saving the life of patients with coronary artery diseases (CADs). However, conventional polymers such as polylactic acid (PLA) and poly (lactic-co-glycolic acid) (PLGA), which are widely applied for ...
Ruixia Hou, Leigang Wu, Jin Wang, Zhilu Yang, Qiufen Tu, Xingcai Zhang, Nan Huang   +6 more
doaj   +1 more source

Cangrelor Bridge for Repeat Cesarean After Third Trimester Percutaneous Coronary Intervention for Total Occlusion NSTEMI

Clinical Case Reports, Volume 14, Issue 6, June 2026.
Visual Summary, case timeline of non‐ST‐elevation MI with PCI followed by cangrelor bridge for classical cesarean delivery. ABSTRACT Acute coronary syndrome is an uncommon but potentially life‐threatening complication in pregnancy, and dual antiplatelet therapy presents challenges in patients requiring cesarean delivery.
Vidya N. Mullangi, Sara Folk, Sneha Sharma, Gillian Belnavis, Shea Macielak, Danielle Blais, Talal Attar, Blair Suter, William H. Marshall V   +8 more
wiley   +1 more source